Daunorubicin Hydrochloride for Injection
| General Information: Daunorubicin
hydrochloride injection is typically utilized for remission induction in acute nonlymphocytic leukemia and acute lymphocytic leukemia. For indication, dosing and other information, please refer to the manufacture package insert. |
| |
| Manufacturer |
Product |
Size |
NDC |
PI |
MSDS |
|
TEVA |
Daunorubicin
(Generic) |
20 mg/4mL
(10 pack) |
00703-5233-13 |
PI |
MSDS |
|
|
| Clinical
Data: For any questions
or for further information
related to Daunorubicin
Hydrochloride
Injection, clinical
pharmacology, additional
indications and usages,
contraindications, warnings,
precautions, adverse reactions,
dosage, administration and/or
storage of this product, please
contact
BDI Pharma or call 1-800-948-9834. |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |